Skip to main content

Table 2 Liver metastases-related characteristics in 30 patients with liver metastases from Nasopharyngeal Carcinoma

From: Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature

  Resection group Control group P value
  (n = 15) (n = 15)  
Lesion numbers    >0.999
 <3 12 (80%) 11 (73.3%)  
 ≥3 3 (20%) 4 (26.7%)  
Size of largest metastasis (cm)    0.450
 <5 8 (53.3%) 11 (73.3%)  
 ≥5 7 (46.7%) 4 (26.7%)  
Pathological type    >0.999
 Undifferentiated 15 (100%) 15 (100%)  
 Other types 0 (0%) 0 (0%)  
Dose of Primary Radiotherapy (Gy)    >0.999
 Nasopharyngeal 70 (68–76) 70 (66–78)  
 Regional lymph nodes 66 (50–68) 64 (50–70)  
Adjuvant chemotherapy cycles of NPC    0.390
 <3 10 (66.7%) 13 (86.7%)  
 ≥3 5 (33.3%) 2 (13.3%)  
Pre-resection/TACE comorbidities    
 Present 3 (20%) 4 (26.7%) >0.999
 Absent 12 (80%) 11 (73.3%)  
Post-resection/TACE comorbidities    0.651
 Present 2 (13.3%) 4 (26.7%)  
 Absent 13 (86.7%) 11 (73.3%)  
Hospital mortality 0 (0%) 0 (0%) >0.999
  1. Continuous data were expressed as median (range).
  2. Categorical variables were reported with (%).
  3. NPC: nasopharyngeal carcinoma.
  4. TACE: trans-hepatic arterial chemoembolization.
\